Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group.

Issaragrisil, S; Kaufman, D W; Anderson, T; Chansung, K; Thamprasit, T; Sirijirachai, J; Piankijagum, A; Porapakkham, Y; Vannasaeng, S; Leaverton, P E; Shapiro, S; Young, N S

Issaragrisil, S; Kaufman, D W; Anderson, T; Chansung, K; Thamprasit, T; Sirijirachai, J; Piankijagum, A; Porapakkham, Y; Vannasaeng, S; Leaverton, P E; Shapiro, S; Young, N S.

Affiliation

Issaragrisil S; Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Blood ; 89(11): 4034-9, 1997 Jun 01.

Article in En | MEDLINE | ID: mdl-9166842

Subject(s)

Anemia, Aplastic; Benzothiadiazines; Diuretics/adverse effects; Mebendazole/adverse effects; Sodium Chloride Symporter Inhibitors/adverse effects; Sulfonamides/adverse effects; Adolescent; Adult; Anemia, Aplastic/epidemiology; Anemia, Aplastic/etiology; Case-Control Studies; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Multivariate Analysis; Risk; Thailand/epidemiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Sulfonamides / Benzothiadiazines / Diuretics / Sodium Chloride Symporter Inhibitors / Anemia, Aplastic / Mebendazole Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Blood Year: 1997 Document type: Article

Search on Google

XML

PubMed Links